Natus Medical Incorp secures last-minute Real Value of $41.785 per share. The latest price of the firm is $32.9. At this time the firm appears to be under valued. Macroaxis forecasts value of Natus Medical Incorp from analyzing the firm fundamentals such as Current Valuation of 1.13B, Profit Margin of
(4.05)% and Return On Equity of (4.83)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|
Natus Medical Incorporated is rated third in price to book category among related companies. It is rated fourth in beta category among related companies totaling about 0.32 of Beta per Price to Book. The ratio of Price to Book to Beta for Natus Medical Incorporated is roughly 3.11